3D-printed medications

They are round, oval or rectangular, colorful or white—the structured tablets from the US company Laxxon Medical, in which Evonik Venture Capital recently invested. Laxxon simply prints out the pills using a new type of 3D screen printing technology. The multi-layer structure enables the controlled release of the active pharmaceutical ingredients over an extended period of time. In addition, several ingredients can be combined with each other in this way. Polymers from Evonik ensure the targeted release of the active ingredients. “The technology is a great benefit for patients,” says Bernhard Mohr, the head of Evonik Venture Capital. “It reduces side effects and the number of tablets a patient has to take. This lowers the risk of forgetting an important medication.”